Sectors
EVGN
Evogene Ltd.
0.54
2 x 0.38
2 x 0.71
bid
ask
-
0.01
1.49%
02:09 PM
timesize
| Ytd | -50.78% | |
| 1y | -56.69% |
0.53
day range
0.55
0.37
52 week range
1.50
| Open | 0.55 | Prev Close | 0.55 | Low | 0.53 | High | 0.55 | Mkt Cap | 8.61M |
| Vol | 25.10K | Avg Vol | 1.88M | EPS | -1.75 | P/E | N/A | Forward P/E | -0.39 |
| Beta | 1.40 | Short Ratio | 0.04 | Inst. Own | 11.12% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-19 | 50-d Avg | 0.53 | 200-d Avg | 0.81 | 1yr Est | 8.13 |
| Income Statement | |||
| Total Revenue | 347.00K | ||
| Revenues (USD) | 347.00K | ||
| Cost of Revenue | 206.00K | ||
| Gross Profit | 141.00K | ||
| Operating Expenses | 2.70M | ||
| Research and Development Expense | 1.37M | ||
| Selling, General and Administrative Expense | 1.21M | ||
| Operating Income | -2.56M | ||
| Interest Expense | 168.00K | ||
| Net Income | -1.77M | ||
| Net Income Common Stock | -1.77M | ||
| Net Income Common Stock (USD) | -1.77M | ||
| Consolidated Income | -1.77M | ||
| Net Income from Discontinued Operations | 176.00K | ||
| Net Income to Non-Controlling Interests | -1000 | ||
| Earnings per Basic Share | -0.14 | ||
| Earnings per Basic Share (USD) | -0.14 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -1.60M | ||
| Earning Before Interest & Taxes (USD) | -1.60M | ||
| Weighted Average Shares | 12.20M | ||
| Weighted Average Shares Diluted | 12.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.35M | ||
| Cash and Equivalents (USD) | 9.35M | ||
| Trade and Non-Trade Receivables | 1.41M | ||
| Current Assets | 10.85M | ||
| Property, Plant & Equipment Net | 2.06M | ||
| Total Assets | 13.44M | ||
| Debt Current | 668.00K | ||
| Total Debt | 2.10M | ||
| Current Liabilities | 3.04M | ||
| Debt Non-Current | 1.43M | ||
| Total Liabilities | 7.67M | ||
| Accumulated Retained Earnings (Deficit) | -290.19M | ||
| Shareholders Equity | -3.29M | ||
| Shareholders Equity (USD) | -3.29M | ||
| Assets Non-Current | 2.59M | ||
| Total Debt (USD) | 2.10M | ||
| Deferred Revenue | 86.00K | ||
| Inventory | 93.00K | ||
| Liabilities Non-Current | 4.63M | ||
| Trade and Non-Trade Payables | 696.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 149.00K | ||
| Net Cash Flow from Financing | -1.84M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 805.00K | ||
| Capital Expenditure | 80.00K | ||
| Issuance (Purchase) of Equity Shares | 805.00K | ||
| Issuance (Repayment) of Debt Securities | -117.00K | ||
| Net Cash Flow from Investing | 4.62M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.93M | ||
| Net Cash Flow from Operations | -1.97M | ||
| Effect of Exchange Rate Changes on Cash | -5.00K | ||
| Share Based Compensation | 93.00K | ||